Summary of the EMA March 2022 Draft Qualification Opinion for PROCOVA™
March 22, 2022
Learn more about the highlights, implications, and FAQs concerning the European Medicines Agency’s draft qualification opinion for our 3-step PROCOVA™ procedure.
Recruit Rockstars Podcast #367: How His VC-Backed Team Made Drug Development Faster
November 15, 2020
Unlearn helps biopharma companies develop drugs more efficiently by leveraging AI to reduce the number of patients required for placebo controls in clinical trials.
The Rock Health team reflects on the evolution of digital in clinical trials, discuss the current state, and explore the opportunity to further transform drug discovery.
Applying Machine Learning to Increase Clinical Trial Efficiency: A Regulatory Journey
May 19, 2022
Learn about the evolution of ideas that led to our TwinRCT™ solution for smaller, more efficient clinical trials and recent EMA draft qualification opinion.
Broadening Role for External Control Arms in Clinical Trials
July 12, 2019
Unlearn.AI Inc. is going a step further, using data from historical trials and patient registries to build algorithms that simulate artificial patients.
The ability to reduce the burden on control subjects with subjects in clinical trials for complex diseases like Alzheimer’s Disease would drastically improve the search..
